A JeT promotor–driven vector is currently being tested in an AAV gene therapy clinical trial for giant axonal neuropathy (ClinicalTrials.gov Identifier: NCT02362438) and CLN7 Batten disease (NCT04737460). The gene discussed is MFSD8; the disease is juvenile neuronal ceroid lipofuscinosis.